Procter & Gamble (NYSE:PG) Trading Up 0% – Should You Buy?

The Procter & Gamble Company (NYSE:PGGet Free Report) shares traded up 0% during trading on Friday . The company traded as high as $166.50 and last traded at $166.01. 949,626 shares changed hands during trading, a decline of 69% from the average session volume of 3,098,907 shares. The stock had previously closed at $165.98.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. DA Davidson restated a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Friday, December 27th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. JPMorgan Chase & Co. raised their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Finally, Piper Sandler began coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $180.45.

Check Out Our Latest Research Report on Procter & Gamble

Procter & Gamble Stock Performance

The stock has a market capitalization of $389.99 billion, a P/E ratio of 28.55, a PEG ratio of 3.70 and a beta of 0.44. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The stock’s 50-day simple moving average is $170.27 and its 200 day simple moving average is $169.85.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter last year, the business posted $1.83 EPS. Research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.31%.

Insider Buying and Selling

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock worth $13,317,460 in the last ninety days. Corporate insiders own 0.18% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

A number of institutional investors and hedge funds have recently bought and sold shares of PG. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble in the second quarter worth $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. RPg Family Wealth Advisory LLC purchased a new position in shares of Procter & Gamble during the 3rd quarter valued at about $33,000. Quest Partners LLC purchased a new stake in Procter & Gamble in the second quarter worth approximately $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in Procter & Gamble during the second quarter valued at approximately $44,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.